Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/22—Hormones
  • A61K38/27—Growth hormone [GH], i.e. somatotropin
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • C07K14/575—Hormones
  • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/22—Hormones
  • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/02—Inorganic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
  • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
  • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • C07K14/575—Hormones
  • C07K14/61—Growth hormone [GH], i.e. somatotropin
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K2319/00—Fusion polypeptide
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K2319/00—Fusion polypeptide
  • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Endocrinology (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Organic Chemistry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• Gastroenterology & Hepatology (AREA)
• Zoology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Epidemiology (AREA)
• Molecular Biology (AREA)
• Toxicology (AREA)
• Biophysics (AREA)
• Genetics & Genomics (AREA)
• Biochemistry (AREA)
• Immunology (AREA)
• Reproductive Health (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Diabetes (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Inorganic Chemistry (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Peptides Or Proteins (AREA)
• Medicinal Preparation (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Dermatology (AREA)
• Oil, Petroleum & Natural Gas (AREA)

Applications Claiming Priority (3)

Publications (2)

Family

ID=52992360

Family Applications (1)

Country Status (20)

Families Citing this family (3)

Family Cites Families (37)

• 2014
  • 2014-10-21 DK DK14856666.4T patent/DK3060239T3/da active
  • 2014-10-21 AU AU2014338575A patent/AU2014338575B2/en active Active
  • 2014-10-21 CN CN201480070117.5A patent/CN106163543A/zh active Pending
  • 2014-10-21 MX MX2016005227A patent/MX2016005227A/es unknown
  • 2014-10-21 TW TW103136384A patent/TWI720939B/zh active
  • 2014-10-21 TW TW110104795A patent/TWI777407B/zh active
  • 2014-10-21 ES ES14856666T patent/ES2811068T3/es active Active
  • 2014-10-21 TW TW103143380A patent/TWI720940B/zh active
  • 2014-10-21 SI SI201431630T patent/SI3060239T1/sl unknown
  • 2014-10-21 KR KR1020247021540A patent/KR20240110069A/ko active Search and Examination
  • 2014-10-21 KR KR1020227031563A patent/KR20220130254A/ko not_active IP Right Cessation
  • 2014-10-21 KR KR1020217030424A patent/KR102444140B1/ko active IP Right Grant
  • 2014-10-21 HU HUE14856666A patent/HUE050002T2/hu unknown
  • 2014-10-21 PT PT148566664T patent/PT3060239T/pt unknown
  • 2014-10-21 PL PL14856666T patent/PL3060239T3/pl unknown
  • 2014-10-21 KR KR1020167013555A patent/KR20160068969A/ko active Application Filing
  • 2014-10-21 RU RU2016119565A patent/RU2746943C2/ru active
  • 2014-10-21 WO PCT/IL2014/050910 patent/WO2015059695A1/en active Application Filing
  • 2014-10-21 TW TW103143381A patent/TW201536312A/zh unknown
  • 2014-10-21 TW TW111132309A patent/TW202317176A/zh unknown
  • 2014-10-21 JP JP2016525032A patent/JP6640720B2/ja active Active
  • 2014-10-21 IL IL297219A patent/IL297219B2/en unknown
  • 2014-10-21 EP EP20172836.7A patent/EP3763733A1/en active Pending
  • 2014-10-21 EP EP14856666.4A patent/EP3060239B1/en active Active
  • 2014-10-21 CA CA2928269A patent/CA2928269C/en active Active
• 2016
  • 2016-04-21 MX MX2021003908A patent/MX2021003908A/es unknown
• 2019
  • 2019-12-26 JP JP2019236267A patent/JP7051797B2/ja active Active
• 2020
  • 2020-02-06 AU AU2020200874A patent/AU2020200874A1/en not_active Abandoned
  • 2020-07-15 HR HRP20201114TT patent/HRP20201114T1/hr unknown
• 2022
  • 2022-03-29 JP JP2022052919A patent/JP7445695B2/ja active Active
  • 2022-04-19 NL NL301170C patent/NL301170I2/nl unknown
  • 2022-05-02 HU HUS2200014C patent/HUS2200014I1/hu unknown
  • 2022-07-13 FR FR22C1035C patent/FR22C1035I2/fr active Active
  • 2022-10-07 AU AU2022246472A patent/AU2022246472A1/en active Pending

Also Published As

Similar Documents